This research project was initiated in 2012 in collaboration with Sanaria Inc and the Malaria Research and Training Center at the University of Bamako, Mali. In 2012, we developed the clinical trials protocol for the CVac study, obtained all required approvals, and prepared the study site by December 2012. Due to the civil unrest in Mali the trial could not be started in April 2013 as planned. Since January 2013, we have designed the second study to test the safety, immunogenicity and efficacy against naturally occurring malaria transmission of PfSPZ Vaccine in Malian adults. This protocol has undergone scientific review in July 2013. Together with our collaborators we have decided to give the study testing PfSPZ Vaccine priority. The planned study start is in December 2013.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2013
Total Cost
$165,585
Indirect Cost
City
State
Country
Zip Code
Hoffman, Stephen L; Vekemans, Johan; Richie, Thomas L et al. (2015) The March Toward Malaria Vaccines. Am J Prev Med 49:S319-33
Sahu, Tejram; Lambert, Lynn; Herrod, Jessica et al. (2015) Chloroquine neither eliminates liver stage parasites nor delays their development in a murine Chemoprophylaxis Vaccination model. Front Microbiol 6:283
Hoffman, Stephen L; Vekemans, Johan; Richie, Thomas L et al. (2015) The march toward malaria vaccines. Vaccine 33 Suppl 4:D13-23
Richie, Thomas L; Billingsley, Peter F; Sim, B Kim Lee et al. (2015) Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine 33:7452-61